[Value of neck dissection before definitive radiation therapy for locoregionally advanced squamous cell carcinoma of the head and neck]

Cancer Radiother. 2016 Feb;20(1):18-23. doi: 10.1016/j.canrad.2015.09.008. Epub 2015 Dec 31.
[Article in French]

Abstract

Purpose: Optimal timing of neck dissection remains debated in the conservative management of patients with locoregionally advanced squamous cell carcinoma of the head and neck.

Patients and methods: The files of 63 patients with radiographic evidence of bulky or necrotic nodal metastases treated by up-front neck dissection and definitive radiotherapy between 2000 and 2012 at two institutions were retrospectively reviewed.

Results: The primary site was oropharyngeal, hypopharyngeal or laryngeal in 63%, 21% and 13% cases, respectively. Overall, 83% of the tumours were staged pN2b or more. Extracapsular spread was found in 48 cases (77%). After a 48-month median follow-up, the 3-year locoregional control and overall survival were 88% and 68%, respectively. Only one isolated failure occurred in the dissected neck.

Conclusion: This combination therapy provides a good locoregional tumour control. It should be considered as an option in laryngeal, hypopharyngeal or oropharyngeal squamous cell carcinomas with bulky or necrotic nodal metastases at presentation.

Keywords: Adénopathie; Cancer des VADS; Chimioradiothérapie; Curage ganglionnaire; Head and neck cancer; Neck dissection; Neck nodes; Radiation therapy; Radiothérapie.

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / therapy*
  • Chemotherapy, Adjuvant
  • Dose Fractionation, Radiation
  • Female
  • Follow-Up Studies
  • Head and Neck Neoplasms / mortality
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / therapy*
  • Humans
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neck Dissection*
  • Neoadjuvant Therapy*
  • Radiotherapy, Adjuvant
  • Retrospective Studies